🔗Get a quick preview with this short video below, or dive straight into the full module here: amededu.co/4m4TaaT
#HIV247 #EACCME #LAART #IDSky #MedSky #LongActingTherapy #LongActingART #HIV
This week’s #MondayBites features Dr. José Arribas breaking it down—think clinic setup, team training, and workflow essentials.
🔗Catch the full module on our website: amededu.co/4m4TaaT
#HIV247 #LAART #EACCME #IDSky #MedSky #CME #MedEd
🔗Get a quick preview with this short video below, or dive straight into the full module here: amededu.co/4m4TaaT
#HIV247 #EACCME #LAART #IDSky #MedSky #LongActingTherapy #LongActingART #HIV
i-base.info/htb/52587
#HIVsky #HIVguidelines #HIVtreatment #HIVpositive #PLWH #HIVscience #Undetectable #UequalsU #InjectableART #LongActingART #abacavir #cabotegravir @bhiva.bsky.social @bashhuk.bsky.social
i-base.info/htb/52587
#HIVsky #HIVguidelines #HIVtreatment #HIVpositive #PLWH #HIVscience #Undetectable #UequalsU #InjectableART #LongActingART #abacavir #cabotegravir @bhiva.bsky.social @bashhuk.bsky.social
Researchers interviewed early adopters at three U.S. HIV clinics to better understand the benefits—and challenges—of long-acting cabotegravir/rilpivirine.
pubmed.ncbi.nlm.nih.gov/39568168/
#HIV #LongActingART #HIVResearch
Researchers interviewed early adopters at three U.S. HIV clinics to better understand the benefits—and challenges—of long-acting cabotegravir/rilpivirine.
pubmed.ncbi.nlm.nih.gov/39568168/
#HIV #LongActingART #HIVResearch
🎥Dive deeper with Module 2 of our HIV 24/7 series— #EACCME -accredited & free for regular delegates!
🔗 amededu.co/4m4TaaT
#HIV247 #HIVCare #HIVTreatment #LongActingTherapy #LongActingART #IDSky #MedSky
💡 Check out the full module on Practical Considerations for Long-Acting ART on our website!
🔗 amededu.co/4m4TaaT
#HIV247
🎥Dive deeper with Module 2 of our HIV 24/7 series— #EACCME -accredited & free for regular delegates!
🔗 amededu.co/4m4TaaT
#HIV247 #HIVCare #HIVTreatment #LongActingTherapy #LongActingART #IDSky #MedSky